<SEC-DOCUMENT>0001558370-21-005093.txt : 20210528
<SEC-HEADER>0001558370-21-005093.hdr.sgml : 20210528
<ACCEPTANCE-DATETIME>20210428163147
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001558370-21-005093
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroBo Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		(857) 702-9600

	MAIL ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.10.0.88--><!--Created on: 4/28/2021 08:31:34 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="tmb-20210428xcorresp001.jpg" alt="Graphic" style="display:inline-block;height:81pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:240.75pt;"></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">April 28, 2021</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;text-decoration:underline;text-decoration-color:#000000;">VIA EDGAR</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">U.S. Securities and Exchange Commission</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Division of Corporation Finance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">100 F. Street, NE</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Washington, D.C. 20549</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Attention: Deana Virginio</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:13.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:86.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><b style="font-weight:bold;">Re:</b></p></td><td style="vertical-align:bottom;width:86.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">NeuroBo Pharmaceuticals, Inc.</b></p></td></tr><tr><td style="vertical-align:bottom;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:86.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Registration Statement on Form S-3</b></p></td></tr><tr><td style="vertical-align:bottom;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:86.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">File No. 333-255418</b></p></td></tr><tr><td style="vertical-align:bottom;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:86.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Acceleration Request</b></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:23.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:20.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:23.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:20.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Requested Date:</b></p></td><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">April 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:23.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:20.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Requested Time:</b></p></td><td style="vertical-align:bottom;width:56.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">4:01 P.M. Eastern Time</b></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ladies and Gentlemen:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Pursuant to Rule 461 under the Securities Act of 1933, as amended, NeuroBo Pharmaceuticals, Inc. (the <font style="font-style:italic;font-weight:bold;">&#8220;Company&#8221;</font>) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-255418) (the <font style="font-style:italic;font-weight:bold;">&#8220;Registration Statement&#8221;</font>) be declared effective at the &#8220;Requested Date&#8221; and &#8220;Requested Time&#8221; set forth above, or as soon as practicable thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes each of Phillip D. Torrence, Jeff Kuras and Patrick Valenti of Honigman LLP, counsel to the Company, to make such request on its behalf.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Please confirm the effectiveness of the Registration Statement with Phillip D. Torrence of Honigman LLP by telephone at 269.337.7702, Jeff Kuras of Honigman LLP by telephone at 313.465.7446 or Patrick Valenti of Honigman LLP by telephone at 313.465.7985.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:3.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sincerely,</p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">NEUROBO PHARMACEUTICALS, INC.</p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:3.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:46.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Richard Kang</p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: Richard Kang, Ph.D.</p></td></tr><tr><td style="vertical-align:bottom;width:49.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="3" style="vertical-align:bottom;width:50.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: CEO and President</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:13.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:86.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:13.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">cc:</p></td><td style="vertical-align:bottom;width:86.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Phillip D. Torrence, Honigman LLP</p></td></tr><tr><td style="vertical-align:bottom;width:13.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:86.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Jeff Kuras, Honigman LLP</p></td></tr><tr><td style="vertical-align:bottom;width:13.81%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:86.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patrick Valenti, Honigman LLP</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tmb-20210428xcorresp001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20210428xcorresp001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "B >(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBHYIXK>)I9
MI%2-1DLQP!0!)2$@ DD #N:\_P!=^)4,(:'2(O-?#*97X"GL0.<BN#U'Q-K&
MI3>;/>R@XQMB8H/R%=M+ U)ZRT..>.IQ=HZGN)U;3@2#J%J"/69?\:;_ &SI
MF<?VA:_]_E_QKYY8ECDG.>YIE=/]FQ_F,UC6^A]&+JNG.X1+^U9CP )E)/ZU
M;KYH5FC<.A*L#D,."*Z7POKVO_VO';6=W+*T[!6$G[S"@\D ^U9U,OY5=2-H
M8GFW1[E134#+&H=MS <MC&33J\TZ@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***:[I$C/(ZHBC)9C@
M 4 5]0U"WTRS>YN9 D:#//>O'/$_BFYU^[R"T5HG^KBS^I]ZD\6>(Y]=OV3=
MMM(F/EH#^I]37.'_ #S7M83"JFN>6Y\[C,>ZLN2'P_F1FFD4\UU^B_#V_P!7
MT\7<DZVB/]Q70DL/7VKKJ5(TU>3L94(3J.T%<XJD(&:Z;4?!UWIE\\-U/%'$
M.4F+###Z9JHTVDV VPQ&YEQ@L_W5;Z4E5C)7CJ=*@XOWM#.M=,NKSE(B%!PS
MG@"MS2);/POJ,=^]UY]S$2#%'T(/'>L>[UB]NU*/+MCQ@HG (^E9Y[T.+DK2
MV-X247H?0MCKVGW^C_VI'.!;*NZ1B#\F.H/TKB=0^)<5OXFC%H?/TU5V2$?Q
M$\[E_ES2^&UQ\*M0/<QS?UKRT*68#U-<&'PM-SFGTT.V=65EYGTG9WD%_:1W
M5M()(9!N5AW%3UY9X<\2'P[>66E79VP/&-YZ@,>!_2O4E8,H92"#R".]<%:B
MZ4O+H=$)<R%HHHK$H**S]9UBUT+3S>WA80A@N5&>34&A^)--\0Q2/83%C&<,
MK#!'X&K5*;ASVT[F;JP4^2^O8UZ***@T"BBLO7-?LO#]M'/?,P1VVC:I/-5&
M$IOEBKLF<XP7-)V1J456T^^AU*RCNX"3%(,KD8JS2::=F---704444AA1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<MJ/C_1=,OY;.X>02Q'
M#80G^E:4Z4ZCM!7,ZE6%-7F['4T5QG_"SO#V,^9-_P!^V_PI1\3O#V0#+*/^
MV;?X5K]3Q'\C,?KN'_G1V5%<U8^/?#VH7*P0WA5VZ&1"@_,UTBNKJ&1@RD9!
M!R#64Z4Z>DU8VIU85-8-,6BBBLS0**** "BBB@ HHHH **** "BBB@ HHHH
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M?#34FM/$OV9Y]D$Z$%#T9_X?YFGBZ2E1]"J4[2/:****\([#C?B=_P B<_\
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M*'M:W-4ULKG7CI>RH<M/2[M]YN^#/ D*0#5-9C6XN)QO1&Y"@\Y/J37H04*
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M@!(P_BQT_G6?X8M)[+15AN8S')YTK;3Z%R1^E;%%+G?*XOK;\!^S7,I+I?\
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MU%.CSO5Z=M HHHK$V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
